Procardia patent
Executive Summary
An Alexandria, Virginia federal court has found that New Formulations I, Inc. infringed Pfizer's patent for a capsule formulation of nifedipine the active ingredient in the calcium channel blocker Procardia, Pfizer said Sept. 12. The court's summary judgment was made in the second week of September.